Product information and disease descriptionProduct descriptionProduct information
Dosing and administration
3 evidence topics · 3 sources
Tirabrutinib
Primary central nervous system lymphoma
- Manufacturer
- Deciphera Pharmaceuticals
- Regulatory submission
- NDA submitted December 2025
- Last updated